Randy Ban - 23 Dec 2021 Form 4 Insider Report for Inspire Medical Systems, Inc. (INSP)

Role
Chief Commercial Officer
Signature
/s/ Richard Buchholz, as Attorney-in-Fact for Randy Ban
Issuer symbol
INSP
Transactions as of
23 Dec 2021
Net transactions value
-$2,329,271
Form type
4
Filing time
28 Dec 2021, 16:32:52 UTC
Next filing
06 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction INSP Common Stock Options Exercise $5,908 +2,854 +1151% $2.07* 3,102 23 Dec 2021 Direct F1
transaction INSP Common Stock Options Exercise $5,159 +5,488 +177% $0.9400* 8,590 23 Dec 2021 Direct
transaction INSP Common Stock Sale $2,002,080 -8,342 -97% $240.00 248 23 Dec 2021 Direct F2
transaction INSP Common Stock Options Exercise $1,337 +646 +260% $2.07* 894 27 Dec 2021 Direct
transaction INSP Common Stock Options Exercise $726 +772 +86% $0.9400* 1,666 27 Dec 2021 Direct
transaction INSP Common Stock Sale $340,320 -1,418 -85% $240.00 248 27 Dec 2021 Direct F2
holding INSP Common Stock 167 23 Dec 2021 By son
holding INSP Common Stock 166 23 Dec 2021 By daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -2,854 -24% $0.000000 9,213 23 Dec 2021 Common Stock 2,854 $2.07 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -5,488 -41% $0.000000 8,045 23 Dec 2021 Common Stock 5,488 $0.9400 Direct F3, F4
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -646 -7% $0.000000 8,567 27 Dec 2021 Common Stock 646 $2.07 Direct F3
transaction INSP Stock Option (Right to Buy) Options Exercise $0 -772 -9.6% $0.000000 7,273 27 Dec 2021 Common Stock 772 $0.9400 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 19 additional shares acquired under the Inspire Medical Systems, Inc. 2018 Employee Stock Purchase Plan since the Reporting Person's ownership report filed on January 6, 2021.
F2 The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan dated November 5, 2021.
F3 The option is fully vested and exercisable.
F4 This option grant was previously reported as having an expiration date of December 31, 2026, which has been revised herein.